Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion-insertion R) in an advanced non-small cell lung cancer patient. [PDF]
Thorac CancerTamura A +4 more
europepmc +1 more source
Dabrafenib and trametinib vs anti-PD(L)1 for the adjuvant treatment of locally advanced BRAF-mutant melanoma: a systematic review and meta-analysis. [PDF]
OncologistAraujo DV +4 more
europepmc +1 more source
Regioselective synthesis of 2-(bromomethyl)-5-aryl-thiophene derivatives palladium (0) catalyzed suzuki cross-coupling reactions: as antithrombotic and haemolytically active molecules [PDF]
core +1 more source
Short-term relugolix use for rapidly growing uterine fibroids before uterus-preserving surgery in women seeking to conceive: Two case reports. [PDF]
J Obstet Gynaecol ResIshikawa H +5 more
europepmc +1 more source
Matrix stiffness influences drug resistance to gemcitabine analog and AZD 1775 combination in PDAC organoids. [PDF]
PLoS OneBarajas J +5 more
europepmc +1 more source
Cobb syndrome effectively treated with trametinib. [PDF]
Ann Clin Transl NeurolSun Y, Yang X, Fan X, Su L, Cai R.
europepmc +1 more source
Hydrazine Derivatives as C-Centered Radical Precursors for C-C Bond Formation Reactions. [PDF]
MoleculesLopat'eva ER, Krylov IB, Terent'ev AO.
europepmc +1 more source
Hybrid pH Responsive Supramolecular Polymers Through the Combination of the Ureido-Pyrimidinone Motif with β-Sheet Peptide Sequences. [PDF]
ChemistryBellan R +3 more
europepmc +1 more source
Synthesis of Novel Derivatives of 4,6-Diarylpyrimidines and Dihydro-Pyrimidin-4-one and <i>In Silico</i> Screening of Their Anticancer Activity. [PDF]
Curr Org SynthOnipko OV +5 more
europepmc +1 more source
Is One Year Enough? Extended Adjuvant Dabrafenib Plus Trametinib for Chinese Patients With Resected Stage III Melanoma. [PDF]
J DermatolJia DD +12 more
europepmc +1 more source